VALIANTLAB
Valiant Laboratories Ltd
Each stock's 10,000-path forecast, rendered as light.
Valiant Laboratories Ltd (VALIANTLAB) Stock Analysis & Case Study
What the numbers say about VALIANTLAB, and the method behind each one.
Valiant Laboratories Ltd (VALIANTLAB) trades at ₹79,on the numbers it screens weak, a Downstox Snapshot Score of 31/100.
On the numbers, Valiant Laboratories Ltd (VALIANTLAB) screens weak, a Downstox Snapshot Score of 31/100, weighing premium at 26.4× earnings, ROE of -1.2%, a 49% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
VALIANTLAB fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How VALIANTLAB ranks against the 2,979 companies in our screener
- VALIANTLAB's market cap of 423 Cr ranks in the 37th percentile of the 2,979 NSE companies in our screener, as of 13 Aug 2026.
- VALIANTLAB's book value of ₹57 ranks in the 41st percentile of the 2,979 NSE companies in our screener, as of 13 Aug 2026.
- VALIANTLAB's promoter holding of 74.9% ranks in the 93rd percentile of the 2,979 NSE companies in our screener, as of 13 Aug 2026.
- VALIANTLAB's 3-year profit (PAT) growth of -1.0% ranks in the 26th percentile of the 2,979 NSE companies in our screener, as of 13 Aug 2026.
- VALIANTLAB's 3-year revenue growth of -11.0% ranks in the 9th percentile of the 2,979 NSE companies in our screener, as of 13 Aug 2026.
- VALIANTLAB's debt-to-equity ratio of 0.15x is lower than 72% of the 2,979 NSE companies in our screener, as of 13 Aug 2026.
Is VALIANTLAB overvalued? VALIANTLAB P/E vs peers
VALIANTLAB trades at 26.4× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
VALIANTLAB share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.8y of VALIANTLAB history (-26%/yr drift, 47%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| VALIANTLAB 2027 | ₹45 | ₹82 | ₹150 | -1% |
| VALIANTLAB 2028 | ₹35 | ₹81 | ₹187 | -2% |
| VALIANTLAB 2029 | ₹29 | ₹80 | ₹223 | -2% |
| VALIANTLAB 2030 | ₹24 | ₹80 | ₹265 | -3% |
| VALIANTLAB 2031 | ₹20 | ₹79 | ₹307 | -4% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability VALIANTLAB goes up, or doubles?
The bull case for VALIANTLAB
- Low price-to-book of 1.37×, the market is paying little over the company's net assets.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹223.
The bear case & risks
- VALIANTLAB's P/E of 26.4x is lower than 46% of the 2,979 NSE companies in our screener, as of 13 Aug 2026.
- VALIANTLAB's Piotroski F-Score of 2/8 ranks in the 6th percentile of the 2,979 NSE companies in our screener, as of 13 Aug 2026.
- High historical volatility (47%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹29.
VALIANTLAB volatility & expected range, how bumpy is the ride?
Over the last 2.8 years VALIANTLAB compounded at -26%/year with annualized volatility of 47%. That volatility implies a 1-year 80% range of ₹45-₹150, the honest backbone behind any single price target.
VALIANTLAB price forecast, the full 60-month probability fan
VALIANTLAB price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds VALIANTLAB hits common targets within the simulated horizon?
Full multi-horizon detail on the VALIANTLAB price target & forecast page.
VALIANTLAB Piotroski F-Score: 2/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. VALIANTLAB scores 2/8, weak on the financial-strength checks.
About Valiant Laboratories Ltd: sector, index & market-cap context
Valiant Laboratories Ltd (VALIANTLAB) is a small-cap NSE-listed company, with a market capitalisation of ₹423 Cr. See more stocks on our screener.
How the VALIANTLAB Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Valiant Laboratories Ltd's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
VALIANTLAB analysis, FAQs
Is Valiant Laboratories Ltd (VALIANTLAB) a good buy?
On the numbers, Valiant Laboratories Ltd (VALIANTLAB) screens weak, a Downstox Snapshot Score of 31/100, weighing premium at 26.4× earnings, ROE of -1.2%, a 49% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is VALIANTLAB overvalued or undervalued?
VALIANTLAB trades at 26.4× earnings, premium versus the ~22× long-run Nifty average.
What is the VALIANTLAB share price target for 2031?
VALIANTLAB's probability-weighted 2031 median target is ₹79, with an 80% range of ₹20-₹307 (10,000-path Monte-Carlo).
What is the probability VALIANTLAB doubles in 5 years?
The modelled probability of VALIANTLAB reaching ₹165 (2×) within 5 years is 24%.
What is the bull case for VALIANTLAB?
Low price-to-book of 1.37×, the market is paying little over the company's net assets.
What are the risks in VALIANTLAB?
VALIANTLAB's P/E of 26.4x is lower than 46% of the 2,979 NSE companies in our screener, as of 13 Aug 2026. VALIANTLAB's Piotroski F-Score of 2/8 ranks in the 6th percentile of the 2,979 NSE companies in our screener, as of 13 Aug 2026. High historical volatility (47%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
More on VALIANTLAB
For information and education only. Downstox is a data and analytics platform, not a SEBI-registered Research Analyst or Investment Adviser. Nothing here is investment advice or a recommendation to buy, sell or hold any security. Any scores, ranks, targets or scenarios are model estimates shown with their method, not forecasts or assured outcomes. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing.